Moreover, although different studies described a MEG3 downregulation in MM [43], Allegra et al. [53] have instead found increased levels of MEG3 in patients treated with bisphosphonates that develop osteonecrosis of the jaw (BONJ). Here, MEG3 is linked to Miyoshi myopathy.